No definition available.
Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)
C3_NASAL_CAVITY_SINUSES_EXALLC
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
359 |
4. Check minimum number of eventsNone |
359 |
5. Include endpointsNone |
359 |
6. Filter based on genotype QC (FinnGen only) |
359 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
- Neoplasms
Similar with less cases:
- Malignant neoplasm of nasal cavity and middle ear, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of nasal cavity and sinuses
- Malignant neoplasm of accessory sinuses, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of nasal cavity and middle ear
- Malignant neoplasm of accessory sinuses
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 359 | 148 | 211 |
| Unadjusted period prevalence (%) | 0.08 | 0.05 | 0.09 |
| Median age at first event (years) | 65.70 | 63.79 | 67.04 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 207
- Matched controls
- 2068
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
+∞
126.4
108
*
130
Kela drug reimbursment
Malignant tumour
+∞
78.2
70
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
200.8
68.7
68
5
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
65.1
59
*
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
279.4
61.8
60
*
UDH02
NOMESCO Finland
Rhinopharyngoscopy
23.0
57.5
87
63
WF002
NOMESCO Finland
Radical radiotherapy
371.7
57.3
55
*
H02AB02
ATC
dexamethasone; systemic
78.4
48.1
53
9
8070/3-C30.0
ICD-O-3
Squamous cell carcinoma, NOS, of nasal cavity
+∞
44.4
41
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
43.3
40
*
DHB10
NOMESCO Finland
Excision of lesion of internal nose
+∞
43.3
40
*
A03FA01
ATC
metoclopramide; systemic, rectal
12.0
41.5
84
111
A04AA02
ATC
granisetron; systemic, transdermal
457.2
39.4
38
*
XX3DW
NOMESCO Finland
Time consuming IT work
20.2
37.8
58
39
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
223.7
37.1
37
*
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
+∞
35.4
33
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
7.0
35.2
113
302
C31.0
ICD-10 Finland
Malignant neoplasm: Maxillary sinus
+∞
34.3
32
*
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
394.1
33.9
33
*
UDM02
NOMESCO Finland
Sinoscopy
27.6
32.1
44
20
A04AA01
ATC
ondansetron; systemic, rectal
37.7
31.8
40
13
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
29.9
28
*
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
+∞
28.8
27
*
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
322.6
28.5
28
*
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
160.9
27.3
28
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
27.8
27.2
37
16
ZX090
NOMESCO Finland
Other technic of radiotherapy
295.5
26.3
26
*
L03AA02
ATC
filgrastim; parenteral
+∞
25.5
24
*
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
26.0
25.3
35
16
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
24.5
23
*
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
+∞
24.5
23
*
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
269.8
24.2
24
*
R04.0
ICD-10 Finland
Epistaxis
9.1
23.9
53
75
D38.51
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other accessory sinus
+∞
23.4
22
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
23.4
22
*
8720/3-C30.0
ICD-O-3
Malignant melanoma, NOS, of nasal cavity
+∞
23.4
22
*
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
22.8
23.0
33
17
N02AA05
ATC
oxycodone; systemic
6.7
22.7
64
129
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
22.3
21
*
Z51.5
ICD-10 Finland
Palliative care
27.8
21.5
29
12
C31.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of accessory sinuses
+∞
21.2
20
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
21.2
20
*
DJB10
NOMESCO Finland
Excision of septum of nose
+∞
20.1
19
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
20.1
19
*
DPA30
NOMESCO Finland
Sphenotomy
116.2
19.9
21
*
EP1AE
NOMESCO Finland
Neck ultrasound examination
12.5
19.3
35
33
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
+∞
19.0
18
*
8070/3-C31.0
ICD-O-3
Squamous cell carcinoma, NOS, of maxillary sinus
+∞
19.0
18
*
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
9.3
18.7
40
52
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
+∞
18.0
17
*
DHB40
NOMESCO Finland
Conchotomy
196.0
17.8
18
*
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
196.0
17.8
18
*
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
12.8
17.4
31
28
SAA03
NOMESCO Finland
Extended examination of mouth
3.7
17.1
104
443
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
16.9
16
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
+∞
16.9
16
*
EEB00
NOMESCO Finland
Partial excision of maxilla
+∞
16.9
16
*
D38.58
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of other respiratory organ
184.1
16.7
17
*
WX408
NOMESCO Finland
General anesthesy, balanced
4.1
16.5
76
254
ZZQ00
NOMESCO Finland
Free microvascular graft of skin
+∞
15.8
15
*
WX402
NOMESCO Finland
General anaesthesia
5.0
15.3
53
132
JN4BD
NOMESCO Finland
Extensive body CT
8.7
15.1
33
44
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
14.8
14
*
DPC35
NOMESCO Finland
Extensive endoscopic excision of lesion or neoplasm extending to more than one paranasal sinus
+∞
14.8
14
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.3
14.6
103
476
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
6.1
14.4
41
81
A07AA02
ATC
nystatin; oral
7.3
14.3
35
56
ZXC95
NOMESCO Finland
Use of surgical navigator
32.6
14.1
18
6
UDQ12
NOMESCO Finland
Flexible laryngoscopy
7.6
14.0
33
50
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
14.2
13.8
23
18
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
13.7
13
*
9522/3-C30.0
ICD-O-3
Olfactory neuroblastoma of nasal cavity
+∞
13.7
13
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
13.7
13
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
13.7
13
*
C72.2
ICD-10 Finland
Malignant neoplasm: Olfactory nerve
+∞
13.7
13
*
PJD81
NOMESCO Finland
Excision of lymph nodes from upper part of neck
149.3
13.6
14
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
149.3
13.6
14
*
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
43.1
13.4
16
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
7.1
12.9
32
52
EN1AD
NOMESCO Finland
CT examination of mouth and soft tissues of neck
74.5
12.7
14
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
12.6
12
*
L03AA13
ATC
pegfilgrastim; parenteral
+∞
12.6
12
*
A04AD12
ATC
aprepitant; systemic
+∞
12.6
12
*
C03.0
ICD-10 Finland
Malignant neoplasm: Upper gum
+∞
12.6
12
*
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
138.0
12.6
13
*
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
15.7
12.6
20
14
TPH07
NOMESCO Finland
Cathetrisation of artery
5.3
12.1
38
84
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.1
11.7
26
36
WW500
NOMESCO Finland
Blood transfusion
12.9
11.6
20
17
C31.9
ICD-10 Finland
Malignant neoplasm: Accessory sinus, unspecified
+∞
11.6
11
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
11.6
11
*
9680/3-C30.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasal cavity
+∞
11.6
11
*
EEB10
NOMESCO Finland
Maxillectomy
+∞
11.6
11
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
11.6
11
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
15.0
11.2
18
13
QAB10
NOMESCO Finland
Major dressing of wound of skin of head or neck
45.9
11.0
13
*
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
19.1
10.9
16
9
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
63.3
10.7
12
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
63.3
10.7
12
*
ZZF00
NOMESCO Finland
Graft of adipose tissue
115.6
10.5
11
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
10.5
10
*
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
+∞
10.5
10
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
10.5
10
*
D38.50
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of maxillary sinus
+∞
10.5
10
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
20.1
10.4
15
8
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
7.1
10.4
25
39
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
7.9
10.3
23
32
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
4.3
10.3
39
105
QA1S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in head
42.2
10.1
12
*
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
42.2
10.1
12
*
R4190
NOMESCO Finland
Nutritional therapy
11.5
10.0
18
17
WZC30
NOMESCO Finland
Teaching
4.4
9.7
36
95
ZZC00
NOMESCO Finland
Graft of fascia
+∞
9.4
9
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
9.4
9
*
ZZQ20
NOMESCO Finland
Free microvascular graft of skin, muscle and bone
+∞
9.4
9
*
C31.1
ICD-10 Finland
Malignant neoplasm: Ethmoidal sinus
+∞
9.4
9
*
C43.39
ICD-10 Finland
Malignant melanoma of another or unspecified part of the face other or unspecified histology
+∞
9.4
9
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
4.2
9.3
36
99
SBB10
NOMESCO Finland
Teeth copy
6.0
9.3
25
46
D70.82
ICD-10 Finland
Drug-induced neutropenia
38.5
9.1
11
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
3.4
8.8
47
165
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
14.9
8.8
14
10
ZXE20
NOMESCO Finland
More than three and less than five hours
3.5
8.8
43
144
QA4S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in face
52.2
8.8
10
*
WX110
NOMESCO Finland
Local anesthesy
2.5
8.7
138
928
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
4.6
8.5
29
70
R01AD09
ATC
mometasone; nasal
2.4
8.5
96
541
DPB00
NOMESCO Finland
Partial excision of frontal sinus
93.7
8.5
9
*
J33.0
ICD-10 Finland
Polyp of nasal cavity
7.6
8.5
19
27
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
10.1
8.4
16
17
L01CB01
ATC
etoposide; systemic
+∞
8.4
8
*
AAE05
NOMESCO Finland
Nasoendoscopic closure of cerebrospinal fluid fistula
+∞
8.4
8
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
8.4
8
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
8.4
8
*
DLW99
NOMESCO Finland
Other plastic operations on nose
+∞
8.4
8
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
8.4
8
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
8.4
8
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
8.4
8
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.4
8
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.8
8.2
20
32
ZXE40
NOMESCO Finland
More than seven and less than nine hours
10.7
8.2
15
15
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
18.1
8.2
12
7
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
34.8
8.2
10
*
ZZR00
NOMESCO Finland
Flap of skin
23.1
8.1
11
5
GBB00
NOMESCO Finland
Tracheostomy
23.1
8.1
11
5
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.3
7.9
107
653
ZX120
NOMESCO Finland
Intravenous
4.8
7.7
25
58
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
26.1
7.6
10
*
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
82.9
7.5
8
*
GD6AD
NOMESCO Finland
CT of chest and neck
82.9
7.5
8
*
DKW40
NOMESCO Finland
Ligature of artery of internal nose
82.9
7.5
8
*
EBA15
NOMESCO Finland
Extraction of large number of teeth
6.7
7.4
18
29
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
116
Kela drug reimbursment
Prostate cancer
+∞
7.3
7
*
QAB05
NOMESCO Finland
Revision of wound of skin of head or neck
+∞
7.3
7
*
A79
ICPC
Malignancy NOS
+∞
7.3
7
*
D36.7
ICD-10 Finland
Benign neoplasm: Other specified sites
+∞
7.3
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
QAE40
NOMESCO Finland
Repair of anomaly or lesion after disease of skin of head or neck
+∞
7.3
7
*
ZZR50
NOMESCO Finland
Mucoperiosteal flap
+∞
7.3
7
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
7.3
7
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
7.3
7
*
DHB01
NOMESCO Finland
Partial excision of external nose
+∞
7.3
7
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
7.3
7
*
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
16.5
7.3
11
7
JN4AD
NOMESCO Finland
Body CT examination
8.4
7.2
15
19
SPF20
NOMESCO Finland
Temporary soling for filling
20.9
7.2
10
5
ZXA05
NOMESCO Finland
Left side
2.5
7.1
67
336
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.8
7.0
49
207
J33.9
ICD-10 Finland
Nasal polyp, unspecified
14.4
7.0
11
8
H16.0
ICD-10 Finland
Corneal ulcer
5.5
6.8
19
37
EBA10
NOMESCO Finland
Surgical removal of tooth
3.8
6.8
28
82
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
4.1
6.7
25
67
XW000
NOMESCO Finland
Bone marrow biopsy
7.3
6.6
15
22
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
6.1
6.6
17
30
TJD20
NOMESCO Finland
Change of gastrostomy tube
71.9
6.5
7
*
DKW99
NOMESCO Finland
Other procedures for control of epistaxis
71.9
6.5
7
*
ZZA00
NOMESCO Finland
Split skin graft
7.4
6.3
14
20
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
6.1
6.3
16
28
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
6.3
6
*
QAE20
NOMESCO Finland
Excision and repair of scar or web of skin of head or neck
+∞
6.3
6
*
DLD20
NOMESCO Finland
Rhinoplasty
+∞
6.3
6
*
8020/3-C30.0
ICD-O-3
Carcinoma, undifferentiated, NOS, of nasal cavity
+∞
6.3
6
*
C44.32
ICD-10 Finland
Spinocellular carcinoma of the skin on another or unspecified part of the face
+∞
6.3
6
*
CAD00
NOMESCO Finland
Exenteration of orbit with use of graft or flap
+∞
6.3
6
*
8200/3-C30.0
ICD-O-3
Adenoid cystic carcinoma of nasal cavity
+∞
6.3
6
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
6.3
6
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
6.3
6
*
L01AX03
ATC
temozolomide; systemic
+∞
6.3
6
*
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
27.6
6.3
8
*
DKW30
NOMESCO Finland
Cauterisation of artery of internal nose
27.6
6.3
8
*
DHB00
NOMESCO Finland
Excision of lesion of external nose
27.6
6.3
8
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
4.5
6.2
21
51
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
13.0
6.1
10
8
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
9.0
6.1
12
14
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4035726)
119
74
23.56
147.39
1.9
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
190
751
4.25
40.84
3.9
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
115
358
4.25
33.45
5.6
2.7
mmol/l
0.8
0.8
1.07
110
329
(3007853) Bacteria identified in Skin by Aerobe culture
98
308
4.00
27.63
2.4
1.7
—
—
—
0
0
(3002256) Pathology report gross observation
67
172
4.56
24.58
1.3
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
24
11.12
22.92
1.1
1.1
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
99
383
3.19
19.63
2.3
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
143
700
2.73
18.24
3.0
2.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
193
1100
2.63
18.02
5.5
3.6
g/l
33.0
35.4
6.33
181
1001
(3004809) Band form neutrophils/100 leukocytes in Blood
22
28
8.30
16.33
3.0
3.6
%
1.1
0.4
0.95
13
23
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
185
1078
2.48
15.87
5.8
3.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
18
19
9.92
15.34
1.7
1.3
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
203
1262
2.40
14.71
8.0
5.4
mmol/l
1.2
1.2
0.57
165
1073
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
29
57
5.45
14.36
2.3
2.5
mg/l
1.1
1.6
4.97
29
52
(3013650) Neutrophils [#/volume] in Blood by Automated count
212
1353
2.38
14.33
15.8
6.1
e9/l
4.0
4.3
1.19
191
1180
(40768795) Lymph node Pathology biopsy report
19
8
24.97
13.93
1.2
1.0
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
14
11.14
13.84
3.7
4.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
184
1138
2.27
12.95
7.0
4.9
mmol/l
1.2
1.2
0.13
171
994
(42870588) Differential panel, method unspecified - Blood
141
783
2.32
12.82
7.2
5.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
108
538
2.44
12.54
2.5
2.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
14
14
10.37
12.31
1.4
1.3
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
75
318
2.72
12.12
4.1
4.9
mmol/l
1.0
1.0
0.93
70
282
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
12
10
12.38
11.79
1.8
1.4
ug/l
14.7
17.3
—
12
10
(3015377) Calcium [Moles/volume] in Serum or Plasma
142
817
2.22
11.63
5.9
2.0
mmol/l
2.4
2.3
0.54
133
670
(3023368) Bacteria identified in Blood by Culture
124
675
2.28
11.62
5.8
3.7
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
15
18
8.65
11.57
1.3
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
110
587
2.26
10.68
1.4
1.3
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
172
1096
2.09
10.58
7.3
5.2
%
0.6
0.7
1.05
167
1007
(40758558) Short blood count panel - Blood
106
561
2.26
10.47
12.9
4.2
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
10
0
+∞
10.46
6.5
0.0
umol/l
0.3
—
—
10
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
59
240
2.75
10.25
3.4
1.7
nmol/l
396.4
371.1
0.45
54
211
(3019069) Monocytes/100 leukocytes in Blood
175
1137
2.05
10.07
7.3
5.4
%
9.2
8.6
1.62
170
1048
(3006504) Eosinophils/100 leukocytes in Blood
174
1132
2.04
9.94
7.2
5.2
%
2.3
3.0
4.90
168
1039
(3002030) Lymphocytes/100 leukocytes in Blood
176
1151
2.04
9.89
7.2
5.3
%
23.5
27.0
3.86
170
1049
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
22
7.07
9.80
1.9
1.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
187
1261
2.01
9.53
6.7
5.3
e9/l
0.2
0.2
1.14
166
1104
(3027801) Oxygen [Partial pressure] in Arterial blood
66
302
2.45
8.98
6.9
6.2
kpa
14.8
11.4
3.01
61
292
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
66
302
2.45
8.98
6.9
6.2
kpa
5.1
5.2
0.18
61
292
(3003396) Base excess in Arterial blood by calculation
66
304
2.43
8.85
6.9
6.2
mmol/l
0.6
1.6
0.81
51
239
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
10
10.26
8.68
2.1
1.0
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
171
1146
1.94
8.60
6.3
5.1
%
60.1
57.7
1.48
165
1054
(3019198) Lymphocytes [#/volume] in Blood
180
1237
1.91
8.31
6.6
5.1
e9/l
1.8
1.9
0.20
156
1078
(3021879) Hepatitis B virus core Ab [Presence] in Serum
37
131
3.03
8.24
1.5
1.4
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
21
51
4.31
8.11
1.4
1.5
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
178
1226
1.90
8.09
6.6
5.0
e9/l
0.0
0.0
2.13
153
1057
(3001604) Monocytes [#/volume] in Blood
177
1218
1.89
8.06
6.5
5.0
e9/l
0.6
0.6
0.06
152
1046
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
42
162
2.80
8.03
1.3
1.5
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
35
5.05
7.96
1.3
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
51
219
2.55
7.90
1.5
1.4
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
13
21
6.39
7.76
3.3
3.2
%
65.2
52.4
—
5
16
(3018418) pH of Serum or Plasma
121
747
1.93
7.57
5.6
3.2
ph
7.4
7.4
0.03
30
111
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
16
33
5.03
7.48
1.3
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
13
22
6.09
7.43
1.9
1.0
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
64
315
2.26
7.32
1.5
1.4
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
248
1942
1.90
7.16
12.1
5.3
u/l
83.5
76.7
0.79
240
1774
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
61
3.78
7.14
1.5
1.4
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
14
27
5.36
7.02
1.0
1.0
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
41
168
2.63
6.97
3.6
4.7
%
0.4
0.1
0.91
26
42
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
56
268
2.29
6.83
3.6
2.4
umol/l
8.3
9.0
0.08
49
232
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
16
36
4.61
6.77
1.9
7.2
—
123.3
—
0
6
(3017181) Myelocytes/100 leukocytes in Blood
42
177
2.55
6.75
3.6
4.5
%
1.6
0.6
1.19
25
47
(3020779) Urea [Moles/volume] in Serum or Plasma
47
210
2.42
6.68
4.7
6.7
mmol/l
5.8
10.7
9.98
42
197
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
54
259
2.28
6.54
5.1
3.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
85
491
1.96
6.33
4.0
2.1
mmol/l
2.5
2.4
2.81
74
414
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
52
250
2.26
6.26
1.5
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
59
300
2.16
6.20
1.6
1.6
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
117
757
1.81
6.11
2.8
3.0
e6/l
227.0
149.3
0.14
92
583
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
23
5.36
6.05
7.2
3.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
214
2575
0.58
5.68
4.0
4.7
mmol/l
1.4
1.4
0.35
194
2344
(3002179) Metamyelocytes/100 leukocytes in Blood
37
160
2.46
5.64
3.5
4.7
%
1.7
0.2
2.24
18
36
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
9
7
13.14
5.61
3.2
2.7
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
59
314
2.05
5.49
1.9
2.4
%
1.8
1.7
0.19
52
280
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
14
34
4.24
5.41
1.3
1.4
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
129
884
1.72
5.41
2.7
3.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
24
85
2.95
5.36
1.7
3.9
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
150
1077
1.67
5.25
6.3
9.6
inr
1.2
1.4
0.91
46
301
(3013826) Glucose [Moles/volume] in Serum or Plasma
202
1566
1.66
5.25
6.5
4.2
mmol/l
6.8
6.8
0.09
195
1457
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
218
2593
0.59
5.22
3.9
4.7
mmol/l
4.7
4.5
1.21
200
2370
(3044290) Cell count panel - Cerebral spinal fluid
16
46
3.59
4.95
1.8
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
42
206
2.18
4.82
5.8
6.6
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
31
134
2.44
4.74
3.8
1.5
ug/l
3.4
4.8
0.23
24
100
(3030467) Casts [#/volume] in Urine by Automated count
104
693
1.70
4.73
2.6
2.9
e6/l
0.7
0.5
0.18
77
516
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
228
2658
0.61
4.62
4.3
5.3
mmol/l
2.8
2.7
0.75
205
2419
(3018095) Leukocytes [#/volume] in Urine
125
886
1.63
4.45
3.3
3.6
e6/l
34.3
135.6
1.95
95
632
(3000850) Epithelial cells [#/volume] in Urine
81
514
1.74
4.36
2.6
2.3
e6/l
5.2
5.2
0.01
71
443
(3021589) Normoblasts [#/volume] in Blood
145
1074
1.59
4.26
13.6
8.1
e9/l
0.0
0.0
1.08
123
871
(3025159) Blasts/100 leukocytes in Blood
34
161
2.23
4.25
3.8
4.8
%
0.0
0.0
0.49
19
38
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
211
2487
0.63
4.23
3.8
4.2
mmol/l
1.3
1.3
0.47
187
2247
(36304419) Bacteria [Presence] in Urine
97
655
1.66
4.14
2.5
2.9
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
60
949
0.56
4.13
4.8
3.9
mg/mmol
5.1
7.3
0.25
34
605
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
9
276
0.31
4.02
2.0
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
59
926
0.57
3.92
3.7
3.1
mmol/l
8.1
7.7
0.18
48
767
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
11
7.41
3.88
2.1
2.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
52
299
1.86
3.86
2.3
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
52
299
1.86
3.86
2.3
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
19
74
2.66
3.61
3.1
2.5
u/ml
0.3
0.3
0.75
13
37
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
107
763
1.57
3.60
4.7
2.7
u/l
30.6
31.7
0.20
102
728
(3012516) Albumin [Mass/volume] in Urine
58
893
0.58
3.53
3.7
3.2
mg/l
2048.3
241.5
0.68
40
580
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
67
428
1.70
3.49
2.5
1.8
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
17
64
2.74
3.44
1.8
1.6
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
227
2592
0.66
3.37
4.6
4.8
mmol/l
6.0
6.1
0.17
202
2323
(3026782) Osmolality of Urine
75
499
1.64
3.34
2.4
2.6
mosm/kgh2o
534.7
558.6
0.39
63
407
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
8
7.60
3.06
1.7
1.4
nmol/l
21.4
3.8
—
6
8
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
26
129
2.09
2.94
8.2
7.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
10
30
3.40
2.92
2.4
3.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
9
6.76
2.88
3.0
5.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
40
233
1.81
2.87
2.1
2.7
e9/l
70.7
66.1
0.35
31
190
(3016228) CD19 cells/100 cells in Blood
5
6
8.43
2.75
2.4
1.8
%
2.6
2.8
—
5
6
(21494814) CD8 cells/100 lymphocytes in Specimen
5
6
8.43
2.75
2.2
1.8
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
13
48
2.77
2.75
6.2
1.1
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
13
48
2.77
2.75
1.1
1.5
mmol/l
61.8
66.0
0.15
13
41
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
8
19
4.28
2.69
1.3
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
12
43
2.85
2.67
2.2
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
33
186
1.85
2.63
4.8
5.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
11
38
2.95
2.60
1.5
1.3
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
8
20
4.07
2.58
2.5
2.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
9
26
3.52
2.50
2.3
1.1
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
9
26
3.52
2.50
2.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
11
40
2.81
2.39
1.1
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
195
1660
1.38
2.38
4.1
4.3
e6/l
278.7
4260.8
—
10
25
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
28
155
1.87
2.37
2.0
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
31
178
1.81
2.35
3.6
1.3
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
12
47
2.61
2.29
1.3
1.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
224
2502
0.72
2.28
5.4
6.3
mmol/mol
40.1
40.6
0.39
203
2298
(3028026) IgM [Mass/volume] in Serum or Plasma
26
143
1.88
2.25
1.8
1.4
g/l
2.0
1.1
0.74
26
132
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
9
29
3.16
2.24
1.8
1.3
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
62
852
0.67
2.16
3.3
3.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
6
14
4.34
2.16
1.0
1.1
mmol/l
4.2
1.7
—
6
14
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
25
3.25
2.10
1.9
1.7
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
10
5.05
2.07
1.0
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
10
5.05
2.07
2.0
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
15
4.05
2.04
1.0
1.2
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
15
4.05
2.04
1.0
1.2
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
9
32
2.86
2.01
1.7
1.3
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
51
715
0.67
1.95
1.3
1.7
mmol/l
1.4
1.4
0.01
39
598
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
8
27
3.01
1.94
3.9
4.2
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
24
136
1.82
1.92
2.7
2.7
e6/l
0.3
0.2
0.57
24
130
(3008152) Bicarbonate [Moles/volume] in Arterial blood
30
182
1.71
1.92
6.8
7.2
mmol/l
25.2
24.4
0.59
25
173
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
27
436
0.59
1.92
1.1
1.3
iu/ml
21.3
37.8
—
8
143
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
52
2.35
1.89
2.3
1.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
7
22
3.22
1.89
1.7
1.9
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
0
54
0.00
1.87
0.0
1.2
—
0.8
—
0
43
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
6
17
3.57
1.84
1.3
1.2
u/l
36.5
27.1
—
6
12
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
60
2.21
1.80
1.6
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
34
218
1.62
1.78
5.4
2.1
ml/min/173m2
65.6
63.6
0.14
15
82
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
9
36
2.54
1.75
1.2
1.1
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
26
156
1.72
1.74
1.2
1.2
iu/ml
88.6
115.9
—
8
62
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
34
499
0.65
1.62
1.1
1.3
u/ml
5.4
1.5
—
9
131
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
5
14
3.61
1.62
1.6
1.8
u/field
0.6
2.2
—
5
9
(3051651) Icteric interference index of Serum or Plasma
5
14
3.61
1.62
2.6
2.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
43
2.36
1.61
2.1
2.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
27
416
0.62
1.60
1.2
1.3
u/ml
10.5
13.8
—
7
163
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
11
50
2.24
1.58
1.8
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
11
50
2.24
1.58
1.8
1.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
11
50
2.24
1.58
2.5
1.5
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
68
518
1.39
1.57
5.3
4.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
9
185
0.47
1.55
1.1
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
8
33
2.46
1.54
1.6
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
9
37
2.47
1.49
2.6
1.5
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
101
826
1.31
1.47
3.2
2.2
u/l
50.8
57.2
1.61
95
758
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
16
3.15
1.44
1.0
1.1
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
22
2.76
1.44
2.7
3.0
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
6
22
2.76
1.44
3.0
1.7
—
—
—
0
0
(3019225) pH of Specimen
35
240
1.51
1.41
3.8
3.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
9
40
2.28
1.41
1.2
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
17
2.97
1.36
2.6
1.5
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
276
2575
1.31
1.36
26.0
13.0
mg/l
27.4
24.3
0.89
245
1977
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
53
400
1.38
1.31
2.5
2.8
e6/l
2.5
2.6
0.02
30
221
(3000093) Morphology [Interpretation] in Blood Narrative
6
24
2.52
1.31
1.7
1.1
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
24
2.52
1.31
1.3
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
24
2.52
1.31
1.3
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
6
24
2.52
1.31
3.7
1.1
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
24
2.52
1.31
1.3
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
18
2.80
1.29
1.0
1.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
20
123
1.66
1.27
2.7
3.9
mmol/l
26.5
24.4
2.52
20
108
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
25
2.42
1.25
1.3
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
25
2.42
1.25
1.3
1.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
25
2.42
1.25
2.0
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
25
2.42
1.25
1.3
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
5
19
2.65
1.22
3.0
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
155
0.51
1.16
1.3
1.2
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
0
34
0.00
1.16
0.0
1.1
—
20.4
—
0
5
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
59
1.89
1.08
1.3
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
24
344
0.68
1.05
3.6
5.0
%
30.5
32.3
0.62
16
220
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
47
1.94
1.03
1.2
1.1
—
—
—
0
0
(1002224) Polysomnography panel
5
108
0.46
1.02
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
49
617
0.76
0.99
2.7
2.6
ug/l
0.7
0.8
0.29
36
420
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
23
157
1.50
0.99
2.1
1.4
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
17
108
1.60
0.98
5.2
1.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
0
29
0.00
0.98
0.0
1.2
—
—
—
0
0
(4062490)
0
30
0.00
0.97
0.0
1.2
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
0
30
0.00
0.97
0.0
1.2
—
6.4
—
0
22
(3024139) IgG subclass 3 [Mass/volume] in Serum
0
30
0.00
0.97
0.0
1.2
—
0.4
—
0
22
(3028192) IgG subclass 2 [Mass/volume] in Serum
0
30
0.00
0.97
0.0
1.2
—
2.9
—
0
22
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
32
0.00
0.95
0.0
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
27
2.24
0.94
2.3
1.7
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
83
700
1.24
0.94
3.5
2.4
umol/l
321.8
9917.7
3.90
76
595
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
68
561
1.26
0.93
3.3
4.0
ng/l
292.1
366.1
0.16
58
455
(3022217) INR in Platelet poor plasma by Coagulation assay
30
400
0.73
0.90
8.4
23.6
inr
1.3
1.4
—
5
56
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
6
32
1.89
0.82
2.3
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
96
836
1.20
0.80
2.2
2.1
u/l
189.6
235.3
0.43
91
780
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
63
527
1.24
0.77
1.8
1.7
mg/l
2.0
1.2
0.93
52
404
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
78
668
1.21
0.77
2.0
2.1
mg/l
3.0
3.1
0.09
67
563
(3000492) Spirometry study
29
219
1.35
0.76
1.2
1.4
—
—
—
0
0
(4034850)
6
106
0.56
0.73
11.5
10.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
9
56
1.62
0.73
1.4
2.7
—
—
—
0
0
(3044889) 12 lead EKG panel
202
1886
1.16
0.71
4.2
4.0
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
5
26
1.94
0.71
2.0
1.6
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
5
26
1.94
0.71
1.8
1.5
u/field
0.2
1.9
—
5
8
(3022948) Iron [Moles/volume] in Serum or Plasma
48
394
1.25
0.70
2.0
2.3
umol/l
13.2
13.1
0.01
43
352
(40761536) Microorganisms panel - Urine sediment
26
196
1.35
0.70
6.2
3.4
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
206
1931
1.16
0.67
4.7
3.7
pmol/l
14.4
14.9
2.47
195
1731
(3003434) Protein [Mass/volume] in Pleural fluid
5
28
1.80
0.66
1.0
1.3
g/l
39.3
25.9
—
5
23
(3049717) Cytology report of Urine Cyto stain
12
78
1.56
0.66
1.7
1.8
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
41
333
1.26
0.66
2.0
2.4
%
21.0
23.2
0.52
35
283
(3037467) Urinalysis macro (dipstick) panel - Urine
190
1775
1.15
0.64
4.0
4.2
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
8
49
1.65
0.62
1.1
1.9
%
65.8
59.9
—
8
49
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
8
52
1.55
0.60
1.1
2.1
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
6
35
1.73
0.58
1.2
1.3
pmol/l
54.2
54.5
—
6
35
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
51
433
1.21
0.56
2.3
2.6
e6/l
1.0
1.1
0.07
26
253
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
14
99
1.43
0.55
1.9
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
6
38
1.59
0.54
1.2
1.6
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
6
38
1.59
0.54
7.5
4.7
mmol/l
7.3
7.1
—
6
30
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
38
1.59
0.54
1.5
1.2
—
—
—
0
0
(3015736) pH of Urine
89
988
0.87
0.53
3.1
3.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
6
97
0.61
0.53
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
81
900
0.87
0.49
4.4
3.7
%
22.2
24.3
0.52
43
435
(3021901) Oxygen saturation in Capillary blood
7
46
1.53
0.48
5.3
2.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
31
372
0.82
0.46
11.0
7.6
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
108
1172
0.89
0.45
2.1
2.0
pmol/l
88.5
94.3
0.73
58
610
(21494755) Public health laboratory ask at order entry panel
12
163
0.73
0.44
1.2
1.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
69
1.46
0.44
3.0
3.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
69
1.46
0.44
1.4
1.2
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
5
31
1.62
0.43
2.6
1.6
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
104
1127
0.89
0.42
4.0
3.8
ug/l
2.8
2.1
0.34
96
995
(3015171) Extractable nuclear Ab [Units/volume] in Serum
6
94
0.63
0.42
1.2
1.2
—
1.2
—
0
9
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
38
324
1.19
0.42
1.2
1.4
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
251
2423
1.12
0.42
24.7
11.8
ml/min/173m2
82.3
76.6
4.50
220
1948
(3029937) Albumin [Presence] in Urine by Test strip
75
677
1.14
0.41
4.0
4.0
estimate
0.0
0.0
0.00
30
197
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
15
0.00
0.41
0.0
1.5
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
16
0.00
0.41
0.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
8
59
1.36
0.41
1.6
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
113
1048
1.11
0.40
1.9
2.2
nmol/l
74.4
77.1
0.57
100
918
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
16
124
1.30
0.39
1.3
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
5
78
0.64
0.36
1.6
1.6
—
0.3
—
0
18
(3045414) Leukocytes [Presence] in Urine
12
91
1.33
0.34
1.7
2.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
45
1.34
0.34
6.5
2.8
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
63
571
1.13
0.33
1.8
1.7
nmol/l
1112.4
1146.6
0.10
48
422
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
6
88
0.68
0.33
1.5
2.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
106
1131
0.91
0.32
3.6
3.8
ng/l
623.0
79.1
0.46
76
821
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
14
110
1.28
0.32
2.6
1.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
26
221
1.19
0.31
3.3
2.7
kpa
5.1
4.4
0.77
26
211
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
14
175
0.79
0.31
1.6
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
83
768
1.11
0.31
3.0
3.2
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
24
281
0.84
0.30
1.5
1.3
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
284
2898
0.90
0.30
34.7
18.9
e9/l
7.0
6.7
0.64
274
2788
(3026361) Erythrocytes [#/volume] in Blood
284
2898
0.90
0.30
34.7
18.9
e12/l
4.2
4.5
12.18
275
2784
(3013512) EKG study
78
840
0.91
0.29
3.7
3.9
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
284
2896
0.91
0.28
34.8
18.9
e9/l
249.8
243.9
0.73
276
2793
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
32
281
1.15
0.27
1.9
2.7
ug/l
6.1
7.7
0.25
27
242
(3021960) Folate [Moles/volume] in Serum or Plasma
74
686
1.10
0.27
1.6
1.6
nmol/l
20.3
20.6
0.06
66
584
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
13
105
1.25
0.25
1.1
1.0
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
280
2747
1.09
0.24
26.8
15.8
mmol/l
138.8
139.8
5.45
274
2656
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
6
82
0.73
0.24
1.2
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
125
0.79
0.23
1.4
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
237
2314
1.07
0.23
24.3
14.0
%
37.1
40.0
3.96
172
1516
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
5
41
1.22
0.22
1.4
1.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
11
0.00
0.21
0.0
4.4
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.5
—
16.7
—
0
10
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
9.0
—
0
10
(3029075) Extractable nuclear Ab panel - Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
8.7
—
908.1
—
0
12
(4211845)
0
12
0.00
0.21
0.0
4.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
2.1
—
0.9
—
0
7
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
14.5
—
1310.3
—
0
12
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
11
89
1.24
0.21
2.6
2.3
g/l
0.4
0.2
—
6
25
(3019150) Specific gravity of Urine by Refractometry
55
592
0.92
0.21
3.1
4.1
kg/l
1.0
1.0
—
7
88
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(44806420)
0
13
0.00
0.21
0.0
2.5
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
13
0.00
0.21
0.0
1.3
—
154.3
—
0
13
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
57
612
0.92
0.20
1.9
1.7
pmol/l
382.8
11515572.6
0.50
49
495
(3023103) Potassium [Moles/volume] in Serum or Plasma
280
2754
1.08
0.20
27.3
15.9
mmol/l
4.0
4.0
1.39
271
2660
(3036670) Protein [Mass/volume] in Synovial fluid
0
14
0.00
0.20
0.0
1.1
—
35.1
—
0
9
(1761482) Bacteria [#/volume] in Urine by Culture
11
90
1.23
0.19
3.0
4.2
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
235
2396
0.94
0.18
5.3
4.5
mu/l
2.1
2.0
0.96
215
2147
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
157
1.15
0.17
1.6
1.9
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
56
596
0.93
0.17
2.4
3.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
134
1385
0.95
0.17
2.8
2.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
91
870
1.06
0.16
2.8
3.1
ng/l
1354.5
1839.6
0.36
81
743
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
16
139
1.16
0.16
1.4
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
72
688
1.06
0.13
3.9
3.3
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
122
1257
0.96
0.13
4.5
5.0
estimate
0.0
0.0
0.00
30
205
(3009261) Glucose [Presence] in Urine by Test strip
124
1276
0.96
0.13
3.6
3.8
estimate
0.0
0.0
0.00
30
201
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
165
1618
1.04
0.10
3.1
3.0
u/l
51.5
49.4
0.14
154
1494
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
44
1.14
0.10
1.2
1.3
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
268
2707
0.96
0.10
21.5
12.6
—
—
—
0
0
(3020891) Body temperature
13
116
1.13
0.09
2.4
5.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
14
155
0.90
0.09
2.1
3.6
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
97
995
0.97
0.08
3.8
3.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
58
1.04
0.08
1.3
2.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
66
1.06
0.08
1.4
1.6
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
7
68
1.03
0.08
1.6
2.0
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
15
137
1.10
0.07
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
85
0.82
0.07
1.4
1.8
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
9
87
1.04
0.07
1.0
1.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
18
167
1.08
0.07
3.6
3.4
mmol/l
3.1
2.1
0.35
12
122
(40761535) Cells panel - Urine sediment
24
226
1.07
0.07
2.2
3.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
8
95
0.84
0.06
1.8
2.3
u/l
29.1
42.6
—
8
85
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
280
2784
1.03
0.05
14.7
8.9
u/l
25.2
25.7
0.15
273
2651
(3022313) Gas panel - Capillary blood
14
130
1.08
0.04
2.1
3.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
14
149
0.94
0.03
2.3
2.3
%
0.8
1.2
1.93
14
149
(3001122) Ferritin [Mass/volume] in Serum or Plasma
104
1050
0.99
0.02
2.3
2.6
ug/l
203.5
133.5
1.41
95
954
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
17
163
1.05
0.01
1.2
1.3
—
45.7
—
0
12
(3013707) Erythrocyte sedimentation rate by Westergren method
194
1949
0.99
0.01
4.8
4.1
mm/h
17.2
12.5
3.24
188
1763
(3007164) IgA [Mass/volume] in Serum or Plasma
45
443
1.02
0.01
1.4
1.3
g/l
2.4
2.8
0.90
35
260
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
15
144
1.04
0.00
1.8
2.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
125
1256
0.99
0.00
3.5
3.7
estimate
0.0
0.0
0.00
29
206
(3022621) pH of Urine by Test strip
17
167
1.02
0.00
1.7
2.8
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
36
357
1.01
0.00
1.3
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
12
125
0.96
0.00
1.2
1.3
—
—
—
0
0
(4010399)
19
194
0.98
0.00
1.3
1.4
—
—
—
0
0
(3003129) Base excess in Capillary blood by calculation
0
9
0.00
0.00
0.0
1.1
—
2.5
—
0
9
(3039443) Prostate specific Ag panel - Serum or Plasma
5
52
0.96
0.00
1.4
1.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
69.2
—
0
5
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
6
0.00
0.00
0.0
2.2
—
1.3
—
0
6
(3022689) Creatine [Moles/volume] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(4133840)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
(4198724)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
5
58
0.86
0.00
1.2
1.9
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
7
76
0.92
0.00
1.7
1.7
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
27.7
—
0
7
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
59.0
—
0
5
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
13.9
—
0
7
(3002619) Bacteria identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
1.9
—
0
5
(3051101) Glucose [Moles/volume] in Cord blood
0
7
0.00
0.00
0.0
5.6
—
—
—
0
0
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
5
57
0.88
0.00
1.6
2.2
pmol/l
258.8
238.8
—
5
52
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
5
55
0.91
0.00
1.0
1.1
—
1.0
—
0
5
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
25
250
1.00
0.00
1.6
1.3
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
0
5
0.00
0.00
0.0
2.2
—
7.2
—
0
5
(3005082) Progesterone [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
21.7
—
0
5
(3016244) Insulin [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
18.5
—
0
5
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
61
0.98
0.00
1.3
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
8
79
1.01
0.00
1.4
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_NASAL_CAVITY_SINUSES_EXALLC – Malignant neoplasm of nasal cavity and sinuses, excluding all cancers (controls excluding all cancers)
GWS hits: 1
This endpoint is excluded (different definition than used in FinnGen).